Nutritional Risk for Hospitalized Patients With Neurology Disorders in China
Launched by XUANWU HOSPITAL, BEIJING · Jul 14, 2024
Trial Information
Current as of July 24, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial aims to examine the nutritional status of patients who are hospitalized due to neurological disorders, such as stroke or other brain-related conditions, in China. Researchers want to understand how nutrition affects the health outcomes of these patients, as many face serious nutritional challenges that can worsen their condition and lead to longer hospital stays. The study will also create a detailed database to help improve nutrition care for future patients with similar disorders.
To participate in this trial, individuals must be at least 18 years old and have a primary diagnosis of a neurological disorder. Participants will be asked to provide written consent to join the study. It’s important to note that those with a life expectancy of less than three months or deemed ineligible by the researchers will not be included. If eligible, participants can expect to contribute valuable information that could help enhance nutritional support and overall care for people with neurological conditions in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Age ≥ 18 years;
- • 2. The primary diagnosis was neurological disorders;
- • 3. Written informed consent.
- Exclusion Criteria:
- • 1. Life expectancy is \< 3 months;
- • 2. Researchers think other ineligible participant for the study.
About Xuanwu Hospital, Beijing
Xuanwu Hospital, located in Beijing, is a leading clinical research institution renowned for its commitment to advancing medical knowledge and improving patient care. Affiliated with Capital Medical University, the hospital specializes in neurology and rehabilitation, providing a robust framework for innovative clinical trials. With a multidisciplinary team of experienced researchers and healthcare professionals, Xuanwu Hospital focuses on conducting high-quality, ethically sound studies that aim to explore new treatment modalities and enhance therapeutic outcomes. Through its dedication to research excellence and patient-centered approaches, Xuanwu Hospital plays a pivotal role in the advancement of healthcare solutions both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Junwei Hao, PhD
Principal Investigator
Capital Medical University Xuanwu Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported